Internal Medicine, Cardiovascular Disease · Glendale, CA
NPI
1265488845
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
511 Western Ave
Glendale, CA, 91201
Phone (818) 240-5588
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
45,152 services
Medicare patients, 2024
838
Average age 77
Drug cost, 2024
$6.0M
62,871 prescriptions
Company payments, 2025
$1,829
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Razmik Ohanjanian was code J7329 (hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg), 11,300 times for 79 patients. In total Razmik Ohanjanian billed 45,152 services in 122 codes, and Medicare paid $1.2M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-09-10.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J7329 Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | Office | 11,300 | 79 | $5.69 | $64K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 7,568 | 715 | $52.70 | $399K |
| 99213 Office E&M - Established | Office | 2,612 | 759 | $74.62 | $195K |
| 36415 Venipuncture Blood Collection | Office | 1,823 | 783 | $8.65 | $16K |
| 85025 Blood Count | Office | 1,776 | 779 | $7.61 | $14K |
| 80048 Clinical Chemistry | Office | 1,457 | 764 | $8.29 | $12K |
| 80076 Clinical Chemistry | Office | 1,446 | 763 | $8.01 | $12K |
| 80061 Clinical Chemistry | Office | 1,440 | 769 | $13.12 | $19K |
| 83036 Blood Count | Office | 1,403 | 758 | $9.52 | $13K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,366 | 242 | $0.78 | $1,064 |
| 93000 Electrocardiogram | Office | 940 | 642 | $11.67 | $11K |
| 84443 Clinical Chemistry | Office | 845 | 619 | $16.46 | $14K |
| 82668 Clinical Chemistry | Office | 748 | 641 | $18.41 | $14K |
| 83550 Clinical Chemistry | Office | 747 | 641 | $8.57 | $6,402 |
| 82728 Clinical Chemistry | Office | 747 | 641 | $13.36 | $9,980 |
By year: 2022 $1.2M for 47,916 services; 2023 $1.3M for 49,648 services; 2024 $1.2M for 45,152 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,823 | 783 | $8.65 | $16K |
| 85025 Blood Count | 1,776 | 779 | $7.61 | $14K |
| 80048 Clinical Chemistry | 1,457 | 764 | $8.29 | $12K |
| 80076 Clinical Chemistry | 1,446 | 763 | $8.01 | $12K |
| 80061 Clinical Chemistry | 1,440 | 769 | $13.12 | $19K |
| 83036 Blood Count | 1,403 | 758 | $9.52 | $13K |
| 84443 Clinical Chemistry | 845 | 619 | $16.46 | $14K |
| 82668 Clinical Chemistry | 748 | 641 | $18.41 | $14K |
| 82728 Clinical Chemistry | 747 | 641 | $13.36 | $9,980 |
| 83540 Clinical Chemistry | 747 | 641 | $6.34 | $4,736 |
Medicare prescription drug claims, 2024
In 2024, the drug Razmik Ohanjanian prescribed most often to Medicare patients was Rosuvastatin Calcium, with 2,812 prescriptions and refills. In total Razmik Ohanjanian wrote 62,871 Medicare prescriptions that cost $6.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 2,812 | 3,187 | 321 | $12K |
| Metoprolol Succinate Generic | 2,695 | 2,997 | 325 | $15K |
| Atorvastatin Calcium Generic | 2,600 | 2,900 | 284 | $8,525 |
| Pantoprazole Sodium Generic | 2,228 | 2,374 | 272 | $11K |
| Amlodipine Besylate Generic | 1,908 | 2,087 | 230 | $2,960 |
| Gabapentin Generic | 1,889 | 1,939 | 249 | $11K |
| Tamsulosin Hcl Generic | 1,584 | 1,726 | 182 | $7,788 |
| Escitalopram Oxalate Generic | 1,550 | 1,651 | 189 | $4,367 |
| Levothyroxine Sodium Generic | 1,471 | 1,578 | 144 | $6,190 |
| Sertraline Hcl Generic | 1,417 | 1,481 | 173 | $2,691 |
| Losartan Potassium Generic | 1,262 | 1,421 | 145 | $4,386 |
| Omeprazole Generic | 1,130 | 1,205 | 145 | $3,362 |
| Celecoxib Generic | 1,036 | 1,060 | 176 | $16K |
| Carvedilol Generic | 931 | 1,006 | 99 | $2,970 |
| Metformin Hcl Generic | 878 | 987 | 108 | $1,660 |
Brand drugs: 9,789 claims; generic drugs: 52,111 claims; opioid claims: 411.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Razmik Ohanjanian $1,829 ($1,829 in general payments such as food, travel and fees) from 18 companies. The largest payer was Ardelyx, Inc. with $259.
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. ARDX | 14 | $259 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $245 |
| Amgen Inc. AMGN | 12 | $233 |
| Esperion Therapeutics, Inc. ESPR | 9 | $154 |
| GlaxoSmithKline, LLC. GSK | 13 | $151 |
| Aimmune Therapeutics, Inc. | 5 | $124 |
| Novo Nordisk Inc NVO | 5 | $97.81 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $97.44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68.21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $59.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.